ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,240.00
0.00%
Dow Jones
38,239.66
0.40%
Brent Oil
87.37
-0.35%
Bitcoin
62,258.20
-1.18%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. InnoCan Pharma Corporation (QB) (INNPF) Quote

InnoCan Pharma Corporation (QB)

InnoCan Pharma Corporation (QB) (INNPF)

USOTC
0.2081
0.00
(0.00%)
Closed April 29 4:00PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.2081
Bid
0.191
Ask
0.216
Volume
-
0.00 Day's Range 0.00
0.143 52 Week Range 0.3545
Market Cap
56.28M
Previous Close
0.2081
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
7,679
Shares Outstanding
268,001,895
Dividend Yield
-
PE Ratio
-15.00
Earnings Per Share (EPS)
-0.01
Revenue
2.56M
Net Profit
-3.76M

About InnoCan Pharma Corporation (QB)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.innocanpharma.com
Headquarters
Calgary, Alberta, Can
Founded
1970
InnoCan Pharma Corporation (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker INNPF. The last closing price for InnoCan Pharma (QB) was $0.21. Over the last year, InnoCan Pharma (QB) shares have traded in a share price range of $ 0.143 to $ 0.3545.

InnoCan Pharma (QB) currently has 268,001,895 shares outstanding. The market capitalization of InnoCan Pharma (QB) is $56.28 million. InnoCan Pharma (QB) has a price to earnings ratio (PE ratio) of -15.00.

INNPF Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4-0.023-9.952401557770.23110.23110.2081115000.2111CS
120.01276.499488229270.19540.23110.195476790.21816651CS
26-0.0101-4.628780934920.21820.30.195455150.23194836CS
520.065145.52447552450.1430.35450.14355440.24547948CS
156-0.1795-46.3106295150.38761.27060.14272870.50618823CS
260-0.27294-56.73956427740.481041.27060.142196180.43879196CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.33
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.48
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.75
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.53
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.33
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.48
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.75
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.53
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.33
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.48
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.75
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.53
(0.00%)
0
AACGATA Creativity Global
$ 0.87
(0.00%)
0

INNPF Discussion

View Posts
Stock_Doc1 Stock_Doc1 3 years ago
Big catalyst for INNO, files patent application for its CBD-loaded exosome and liposome platform tech:
https://finance.yahoo.com/news/innocan-pharma-announces-filing-pct-201200126.html
👍️0
TsxTracker1 TsxTracker1 3 years ago
No better time to buy the dip ! IMHO
👍️0
BioStocks1 BioStocks1 3 years ago
Hit ATH at $1.65 last week!
👍️0
TsxTracker1 TsxTracker1 3 years ago
InnoCan Pharma receives strong buy recommendation:
https://finance.yahoo.com/innocan-pharma-receives-strong-buy-092917133.html
👍️0
cousin vinny cousin vinny 3 years ago
What happened to the board???
👍️0
cousin vinny cousin vinny 3 years ago
?????
👍️0
Buffalogirl Buffalogirl 3 years ago
Where is the board for this ticker?
👍️0
JohnCM JohnCM 4 years ago
FDA approval.
👍️0
deepdj011 deepdj011 4 years ago
Up to 0,35 Today CAD/$ ...
👍️0
deepdj011 deepdj011 4 years ago
https://www.finanznachrichten.de/nachrichten-2020-05/49598639-internationale-medien-berichten-ueber-cbd-als-moeglichen-covid-19-killer-aktie-legt-weiter-zu-314.htm
👍️0
Luckypennyman Luckypennyman 4 years ago
InnoCan Pharma Collaborates with Tel Aviv University.

InnoCan Pharma Collaborates with Tel Aviv University to Develop a New Revolutionary Approach to Treat the COVID-19 Corona Virus with Exosomes-Loaded CBD


https://www.newsfilecorp.com/release/54575/InnoCan-Pharma-Collaborates-with-Tel-Aviv-University-to-Develop-a-New-Revolutionary-Approach-to-Treat-the-COVID19-Corona-Virus-with-ExosomesLoaded-CBD

👍️0

Your Recent History

USOTC
INNPF
InnoCan Pharma (QB)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved